Cash flow generation shows extreme volatility, evidenced by an OCF/NI ratio of -3.35 in 2026Q1, which underscores a persistent disconnect between accounting losses and operational cash generation.
| Cash from Operations | 592M | 628.5M | 646.6M | 744.2M | 509.3M | 323.8M | 263.5M | 117.58M | -26.1M | 6.67M |
| Operating CF Margin % | - | 25.6% | 25.29% | 28.31% | 19.15% | 17.25% | 21.01% | 12.07% | -2.7% | 0.73% |
| Operating CF Growth % | -26.75% | -2.8% | -13.11% | 46.12% | 57.29% | 22.88% | 124.1% | 550.5% | -491.48% | - |
| Net Income | -137.4M | 0 | -636.7M | -911.2M | -3.96B | -270.5M | -350.6M | -258.63M | -242.16M | -263.93M |
| Depreciation & Amortization | -1.4M | 0 | 727M | 708.3M | 710.5M | 537.8M | 303.2M | 200.54M | 237.22M | 228.46M |
| Stock-Based Compensation | 3.5M | 0 | 59.9M | 109M | 93.9M | 33.3M | 34.2M | 51.38M | 13.71M | 17.66M |
| Deferred Taxes | 0 | 0 | 21.2M | -78.4M | -54.3M | -13.3M | -45.5M | 357K | 19.72M | -36.27M |
| Other Non-Cash Items | 590.5M | 625M | 500.1M | 976.9M | 3.99B | -31.5M | 215.1M | 120.22M | -27.39M | 32.56M |
| Working Capital Changes | -64.3M | 3.5M | -24.9M | -60.4M | -271.9M | 68M | 107.1M | 3.71M | -27.2M | 28.18M |
| Change in Receivables | -28.7M | -5M | 92.6M | -25.5M | -28.3M | -64.1M | 29.9M | -593K | -50.91M | 43.11M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.26M | 5.98M |
| Change in Payables | -8.7M | 22.8M | -15M | 41.2M | -24M | 31.2M | -2.9M | -13.84M | -18.09M | -39.66M |
| Cash from Investing | -258.1M | -263.2M | -236.7M | -237.4M | 57.3M | -4.04B | -2.99B | -140.88M | 11.93M | -40.2M |
| Capital Expenditures | 5.1M | -263.2M | -289.1M | -242.5M | -202.9M | -118.5M | -107.7M | -72.46M | -45.41M | -37.8M |
| CapEx % of Revenue | 0.21% | 10.72% | 11.31% | 9.22% | 7.63% | 6.31% | 8.59% | 7.44% | 4.69% | 4.12% |
| Acquisitions | 0 | 0 | -32M | 5.1M | 260.2M | -3.93B | -2.88B | -68.42M | 57.34M | -2.4M |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -263.2M | 0 | 84.4M | 0 | 0 | 0 | 0 | 0 | 80.88M | 5M |
| Cash from Financing | -448.8M | -343.1M | -470.1M | -496.5M | -759.2M | 4.03B | 2.93B | 75.22M | -32.6M | 22.82M |
| Debt Issued (Net) | -138.5M | -109.4M | -198.1M | -301M | -496.5M | 1.99B | 1.88B | -406.08M | -31.71M | 14.58M |
| Equity Issued (Net) | 31.9M | -224.5M | -200M | -99.5M | -175M | 2.1B | 843.7M | 1.58M | 0 | 0 |
| Dividends Paid | 0 | 0 | -37.7M | -75.5M | -75.4M | -18.9M | 0 | 0 | 0 | 0 |
| Share Repurchases | 31.9M | -224.5M | -200M | -100M | -175M | -159.4M | 0 | 0 | 0 | 0 |
| Other Financing | -342.2M | -9.2M | -34.3M | -20.5M | -12.3M | -38.8M | 200.5M | 479.72M | -896K | 8.24M |
| Net Change in Cash | -111.8M | 34M | -75.5M | 13.9M | -230.8M | 315.2M | 196.3M | 50.55M | -51.96M | -7.47M |
| Free Cash Flow | 597.1M | 365.3M | 357.5M | 501.7M | 306.4M | 205.3M | 155.8M | 47.74M | -71.51M | -31.14M |
| FCF Margin % | 24.4% | 14.88% | 13.98% | 19.08% | 11.52% | 10.94% | 12.42% | 4.9% | -7.38% | -3.39% |
| FCF Growth % | 67.72% | 2.18% | -28.74% | 63.74% | 49.24% | 31.77% | 226.32% | 166.77% | -129.66% | - |
| FCF per Share | 0.93 | 0.54 | 0.52 | 0.75 | 0.45 | 0.32 | 0.36 | 0.17 | -0.23 | -0.10 |
| FCF Conversion (FCF/Net Income) | -4.35x | -3.13x | -1.02x | -0.82x | -0.13x | -1.20x | -0.75x | -0.45x | 0.11x | -0.03x |
| Interest Paid | 0 | 256.3M | 265.3M | 273.5M | 251.5M | 182.4M | 97.5M | 0 | 121.92M | 115.24M |
| Taxes Paid | 0 | 42.1M | 52.9M | 42.9M | 63.7M | 33.9M | 27.6M | 0 | 13.21M | 14.72M |
Persistent organic revenue contraction
According to reported financial statements, Clarivate consistently generates positive operating cash flow despite recurring net losses, with the OCF/NI ratio frequently reaching extreme negative values, such as -3.35 in 2026Q1, highlighting a significant disconnect between accounting profitability and the company's actual cash-generative capacity.
The persistent gap between net income and operating cash flow suggests that non-cash charges, likely related to amortization of acquired intangibles and purchase accounting, are heavily distorting GAAP earnings. Investors should monitor whether this cash-generative ability remains sustainable if organic revenue growth continues to contract.
Based on quarterly data, Clarivate's free cash flow margins have fluctuated significantly, ranging from a low of 8.1% in 2025Q2 to a peak of 57.1% in 2025Q4, indicating that the company's ability to convert operations into free cash is highly sensitive to timing and non-recurring items.
The extreme variance in FCF margins suggests that the company's cash flow profile is not yet stabilized, likely due to the ongoing integration of large-scale acquisitions. This volatility warrants caution, as it complicates the ability to forecast long-term cash availability for debt service or shareholder returns.
As reported in recent filings, Clarivate maintains a capital expenditure to revenue ratio consistently hovering around 10%, which suggests a steady requirement for reinvestment into its proprietary data platforms to maintain the competitive moat provided by its citation and patent indexing services.
This level of capital intensity appears necessary to support the digital infrastructure required for the Web of Science and Derwent products. Analysts should investigate whether this spending is primarily maintenance-oriented or if it includes significant growth-related investments that have yet to yield top-line expansion.
Data from recent quarters reveals inconsistent working capital movements, with changes ranging from a $54.5 million inflow in 2025Q1 to a $52.3 million outflow in 2024Q4, suggesting that the company's cash conversion cycle is subject to significant quarterly variability in collections and payables management.
The lack of a clear trend in working capital changes may indicate challenges in aligning cash inflows with the subscription-based revenue model. Investors should monitor these fluctuations to determine if they reflect seasonal billing patterns or underlying issues in the efficiency of the accounts receivable process.
Based on the provided cash flow statements, Clarivate has prioritized share repurchases, such as the $149.5 million outflow in 2025Q4, even while reporting net losses, which suggests a management focus on supporting equity value despite the absence of consistent GAAP profitability or organic growth.
The decision to return capital to shareholders while simultaneously managing a complex, levered balance sheet may indicate a high degree of confidence in future cash flows. However, this strategy warrants further investigation into whether such outflows are sustainable given the company's current negative net margin profile.
Quick answers to the most common questions about buying CLVT stock.
Clarivate Plc (CLVT) generated $628.5M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Clarivate Plc (CLVT) generated $365.3M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Clarivate Plc (CLVT) spent $263.2M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Clarivate Plc (CLVT) spent $224.5M on share repurchases. This shows the company's commitment to returning capital to its equity investors.